Skip to main content
. 2017 Sep 1;8(45):79991–80001. doi: 10.18632/oncotarget.20620

Figure 2. Predictors for 2-5/6-12-year outcome.

Figure 2

A. Predictors of the GBS disability scale score in 2-5 years group. GBS patients with appearance of abumin-cytologic dissociation (56.00%, 42/75), axonal subtype (53.12%, 17/32), medical history of hypertension (19.09%, 21/110), autonomic dysfunction (59.09%, 65/110) and dyspnea (28.18%, 31/110) had higher GBS disability scale scores than patients without these symptoms in the 2-5 years group (the averages of the GBS disability scale score: 1, 1, 2, 1 and 2, with IQR of 1-4, 0-2, 1-2, 1-4 and 1-2 vs 1, 0, 1, 1 and 1, with IQR of 0-1.5, 0-1, 0-1, 0-1 and 0-2). B. Predictors of the GBS disability scale score in the 6-12 years group. Cranial nerve involvement and sensory deficits were proved to predict the long-term prognosis 6-12 years after acute phase (average of GBS disability scale score, present: 1 and 1, with IQR of 0-2 and 0-2 vs absent: 1 and 1, with IQR of 0-1 and 0-1).